What is LOPJLB’s current signal on TVRD?

LOPJLB’s latest quantitative signal on Tvardi Therapeutics, Inc. (TVRD) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is TVRD in?

Tvardi Therapeutics, Inc. (TVRD) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Tvardi Therapeutics, Inc. (TVRD) do?

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical…

Where is Tvardi Therapeutics, Inc. based / listed?

Tvardi Therapeutics, Inc. is based in US, listed on NASDAQ.

Tvardi Therapeutics, Inc. (TVRD)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$1.03-4.63%Close

SELLCRISIS · day 19

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $10M
Beta: 0.37
P/E (TTM): -0.39

Short % float: 3.69%
Days to cover: 1.0
SI change: -12.2%

1W: -10.43%
1M: -44.02%

vs SPY 1W: -11.60%
vs SPY 1M: -47.01%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Prediction markets

Company news